Literature DB >> 33666502

Maternal systemic vascular dysfunction in a primate model of defective uterine spiral artery remodeling.

Eugene D Albrecht1, Jeffery S Babischkin1, Graham W Aberdeen1, Marcia G Burch2, Gerald J Pepe2.   

Abstract

Uterine spiral artery remodeling (UAR) is essential for placental perfusion and fetal development. A defect in UAR underpins placental ischemia disorders, e.g., preeclampsia, that result in maternal systemic vascular endothelial dysfunction and hypertension. We have established a model of impaired UAR by prematurely elevating maternal serum estradiol levels during the first trimester of baboon pregnancy. However, it is unknown whether this experimental paradigm is associated with maternal vascular endothelial dysfunction. Therefore, in the present study baboons were administered estradiol on days 25-59 of gestation to suppress UAR and maternal vascular function determined on day 165 (term = 184 days) peripherally and in skeletal muscle, which accounts for over 40% of body mass and 25% of resting systemic vascular resistance. Maternal serum sFlt-1 levels were 2.5-fold higher (P < 0.05), and skeletal muscle arteriolar endothelial nitric oxide synthase (eNOS) protein expression and luminal area, and skeletal muscle capillary density were 30-50% lower (P < 0.05) in UAR suppressed baboons. Coinciding with these changes in eNOS expression, luminal area, and capillary density, maternal brachial artery flow-mediated dilation and volume flow were 70% and 55% lower (P < 0.05), respectively, and mean arterial blood pressure 29% higher (P < 0.01) in UAR defective baboons. In summary, maternal vascular function was disrupted in a baboon model of impaired UAR. These results highlight the translational impact of this primate model and relevance to adverse conditions of human pregnancy underpinned by improper uterine artery transformation.NEW & NOTEWORTHY Maternal vascular dysfunction is a hallmark of abnormal human pregnancy, particularly early-onset preeclampsia, elicited by impaired UAR. The present study makes the novel discovery that maternal systemic vascular dysfunction was induced in a baboon experimental model of impaired UAR. This study highlights the translational relevance of this nonhuman primate model to adverse conditions of human pregnancy underpinned by defective UAR.

Entities:  

Keywords:  artery; primate; remodeling; uterine; vascular

Mesh:

Substances:

Year:  2021        PMID: 33666502      PMCID: PMC8260378          DOI: 10.1152/ajpheart.00613.2020

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  56 in total

1.  Structure of anchoring villi and the trophoblastic shell in the human, baboon and macaque placenta.

Authors:  A C Enders; T N Blankenship; A T Fazleabas; C J Jones
Journal:  Placenta       Date:  2001-04       Impact factor: 3.481

2.  Comparative haemodynamic studies of resting and active skeletal muscle in anaesthetised rats: role of nitric oxide.

Authors:  C Hably; J Vág; J Bartha
Journal:  Acta Physiol Hung       Date:  2001

3.  Preeclampsia: an endothelial cell disorder.

Authors:  J M Roberts; R N Taylor; T J Musci; G M Rodgers; C A Hubel; M K McLaughlin
Journal:  Am J Obstet Gynecol       Date:  1989-11       Impact factor: 8.661

4.  Suppression of extravillous trophoblast invasion of uterine spiral arteries by estrogen during early baboon pregnancy.

Authors:  E D Albrecht; T W Bonagura; D W Burleigh; A C Enders; G W Aberdeen; G J Pepe
Journal:  Placenta       Date:  2005-06-28       Impact factor: 3.481

Review 5.  Altered Endothelial Nitric Oxide Signaling as a Paradigm for Maternal Vascular Maladaptation in Preeclampsia.

Authors:  George Osol; Nga Ling Ko; Maurizio Mandalà
Journal:  Curr Hypertens Rep       Date:  2017-09-23       Impact factor: 5.369

Review 6.  VEGF in Signaling and Disease: Beyond Discovery and Development.

Authors:  Rajendra S Apte; Daniel S Chen; Napoleone Ferrara
Journal:  Cell       Date:  2019-03-07       Impact factor: 41.582

Review 7.  Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia.

Authors:  D S Boeldt; I M Bird
Journal:  J Endocrinol       Date:  2016-10-11       Impact factor: 4.286

8.  Vascular endothelial growth factor induced functional and morphologic signs of endothelial dysfunction in isolated arteries from normal pregnant women.

Authors:  Eimantas Svedas; Khalid B Islam; Henry Nisell; Karolina R Kublickiene
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

9.  Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis.

Authors:  Rebecca A Jackson; Kimberly A Gibson; Yvonne W Wu; Mary S Croughan
Journal:  Obstet Gynecol       Date:  2004-03       Impact factor: 7.661

Review 10.  Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia.

Authors:  S W Walsh
Journal:  Semin Reprod Endocrinol       Date:  1998
View more
  4 in total

1.  Placental sFlt-1 Gene Delivery in Early Primate Pregnancy Suppresses Uterine Spiral Artery Remodeling.

Authors:  Graham W Aberdeen; Jeffery S Babischkin; Jonathan R Lindner; Gerald J Pepe; Eugene D Albrecht
Journal:  Endocrinology       Date:  2022-04-01       Impact factor: 4.736

Review 2.  Novel Technologies for Target Delivery of Therapeutics to the Placenta during Pregnancy: A Review.

Authors:  Gerald J Pepe; Eugene D Albrecht
Journal:  Genes (Basel)       Date:  2021-08-17       Impact factor: 4.096

Review 3.  Placental Ischemia Says "NO" to Proper NOS-Mediated Control of Vascular Tone and Blood Pressure in Preeclampsia.

Authors:  Ana C Palei; Joey P Granger; Frank T Spradley
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

4.  B-flow/spatiotemporal image correlation M-mode: novel ultrasound method that detects decrease in spiral artery luminal diameter in first trimester in primate model of impaired spiral artery remodeling.

Authors:  O M Turan; J S Babischkin; G W Aberdeen; S Turan; C R Harman; G J Pepe; E D Albrecht
Journal:  Ultrasound Obstet Gynecol       Date:  2022-03       Impact factor: 8.678

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.